Virax Biolabs Group Limited (VRAX) Annual Balance Sheets

Annual · GAAP · USD millions
Access VRAX quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Virax Biolabs Group Limited's liquidity, leverage, and long-term financial structure.
Annual Report, GAAP in USD millions
ITEM
(Mar 31 2025)
(Mar 31 2024) (Mar 31 2023) (Mar 31 2021)
Assets
Cash & cash equivalent0.00
Cash, Cash Equivalents Other4.23
Cash & Short-term Investments4.00
Accounts receivable0.00
Inventories0.09
Other Current Assets0.00
Total Current Assets4.89
Equipment/Property/Plant Net1.23
Intangible Assets0.00
Tax Assets, Noncurrent1.30
Other Assets, Noncurrent0.00
Current Prepaid Expenses And Deposits0.51
Current Value Added Tax Receivables0.22
Intangible Assets Other Than Goodwill-
Rightofuse Assets0.21
Total Assets6.43
Liabilities
Current Accounts Payable AndAccrued Liabilities0.00
Other Liabilities, Current0.00
Total Current Liabilities0.67
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
NoncurrentLeaseLiabilities0.18
Trade And Other Current Payables To Related Parties-
Current Debt Instruments Issued-
Deferred Income Including Contract Liabilities-
Total Liabilities0.96
Stockholders' Equity
Other Equity0.00
Common Stockholder's Equity5.46
Total Stockholder's Equity5.46
Liabilities & Stockholder's Equity6.43
4 historic quarters locked

Sign in to unlock the full Virax Biolabs Group Limited balance sheet history.

About Virax Biolabs Group Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-295158

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License